The United States and Japan have agreed on a trade deal to strengthen their battery supply chains and reduce their dependence on China on electric vehicle battery minerals.
The agreement will also give Japanese automakers easier access to the $7,500 US EV tax credit.
It also prohibits the two countries from enacting bilateral export restrictions on the minerals, including lithium, nickel, cobalt, graphite, and manganese, which are most critical for EV batteries.
US and Japan are collaborating to combat “non-market policies and practices” of other countries in the sector and on conducting investment reviews of foreign investments in their critical minerals supply chains.
Minerals-focused trade deals are one way the US will open access for trusted allies to the $7,500 per vehicle EV tax credits in last year’s climate-focused Inflation Reduction Act.
The two countries agreed to review the minerals agreement every two years, including whether it is appropriate to terminate or amend it.


Bulgaria Election 2026: Rumen Radev’s Landslide Victory Signals Political Shift and Economic Implications
Gold Prices Slip Amid Iran Tensions and Fed Chair Uncertainty
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
U.S. Labor Secretary Lori Chavez-DeRemer Steps Down, Deputy to Serve as Acting Chief
U.S. Stock Futures Fall as Iran Tensions Escalate and Oil Prices Surge
Energy Price Spike Won't Trigger Lasting Inflation, Analysts Say
U.S.-Iran Tensions Escalate as Hormuz Crisis Deepens Amid Ceasefire Strains
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Keir Starmer Faces Resignation Pressure Over Mandelson Appointment Controversy
We combed through old botanical surveys to track how plants on Australia’s islands are changing
Oil Prices Surge Amid Middle East Tensions as Global Markets React Cautiously
KOSPI Hits Record High as AI Chip Demand Lifts SK Hynix and Samsung Stocks
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed 



